The Market Reports

Synopsis
The global market for Europium Nanoparticle in Biological Sector was estimated to be worth US$ 14 million in 2024 and is forecast to a readjusted size of US$ 25.5 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Europium (Eu), a rare earth element, has been widely explored for its applications in biological immunofluorescence diagnosis due to its unique luminescent properties. Here is an overview of why and how it's used: Long Fluorescence Lifetimes: Europium complexes have fluorescence lifetimes of microseconds to milliseconds, which are significantly longer than conventional organic fluorophores. This time gap allows researchers to perform time-gated detection, reducing autofluorescence from biomolecules and background noise, thus improving the sensitivity and accuracy of assays. High Stability: Europium chelates or cryptates are highly stable, providing consistent fluorescence signals that don't photobleach. The stability of these fluorescent compounds ensures the reliability of diagnostic tests over extended periods. Sharp Emission Spectra: Europium complexes exhibit sharp emission spectral peaks, which enables multiplexing, meaning several different probes can be detected simultaneously without overlap. This is particularly useful in high-throughput screening or when it's necessary to detect multiple targets at once. In terms of application in biological immunofluorescence diagnosis, europium-labeled immunoassays are commonly used. These techniques involve creating a complex between europium and an antibody specific to the target antigen. When the antigen is present, the europium-labelled antibody binds to it. The resulting complex can then be detected through the characteristic fluorescence of europium, allowing accurate identification and quantification of the target antigen. Overall, the use of europium in biological immunofluorescence diagnostics continues to be a promising field, potentially contributing to the development of more accurate, sensitive, and high-throughput diagnostic methods.
Europium's prolonged fluorescence emission has made it a popular choice for time-resolved fluorometry, a technique often used in immunoassays to increase signal-to-noise ratio, providing highly accurate results.
The development of Europium-doped nanoparticles has expanded potential applications in diagnostics. They provide enhanced stability, sensitivity, and specificity in detecting biomarkers for various diseases.
Initiatives by governments and health organizations worldwide to improve healthcare infrastructure and diagnostic capabilities could lead to greater adoption of advanced diagnostic techniques, including Europium-based immunofluorescence.
With increasing incidences of diseases such as cancer, cardiovascular disease, and diabetes, there's a growing need for advanced diagnostic techniques. Europium-based fluorescence assays could play a key role due to their high sensitivity and specificity.
This report aims to provide a comprehensive presentation of the global market for Europium Nanoparticle in Biological Sector, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Europium Nanoparticle in Biological Sector by region & country, by Type, and by Application.
The Europium Nanoparticle in Biological Sector market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Europium Nanoparticle in Biological Sector.
Market Segmentation
By Company
Thermo Fisher Scientific
Merk
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microdetection
PuriMag
YUAN  BIOTECH
Segment by Type
300 nm
200 nm
100 nm
Other
Segment by Application
Tumor Marker Testing
Thyroid Function Testing
Sex Hormone Testing
Infectious Disease Testing
Cardiovascular and Cardiac Biomarkers Testing
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Europium Nanoparticle in Biological Sector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Europium Nanoparticle in Biological Sector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Europium Nanoparticle in Biological Sector in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index